Active — Not RecruitingNot Applicable

OST and MORES in Male Osteoporosis

Turkey (Türkiye)140 participantsStarted 2026-02-04

Plain-language summary

The aim of this study is to compare the Male Osteoporosis Risk Score and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in male individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of male osteoporosis.

Who can participate

Age range50 Years – 75 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

İnclusion criteria: * Men aged 50-75 * Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital Exclusion criteria: * Patients younger than 50 or older than 75 years of age * Patients with secondary osteoporosis * Female patients * Patients with uncontrolled severe comorbid conditions * Patients with a history of pathological fractures

What they're measuring

Dual energy Xray Absorptiometry (DEXA)

Timeframe: January 2021-January 2024

OST

Timeframe: January 2021-January 2024

Trial details

NCT IDNCT07518212

SponsorKayseri City Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-07-01

View on ClinicalTrials.gov More Male Osteoporosis trials